Review
Aug 2026
Updates in systemic therapy for refractory thyroid carcinoma - targeted agents, immunotherapy, and chemotherapy.
This review summarizes recent practice-changing developments in radioiodine-refractory differentiated thyroid carcinoma, with brief updates on medullary and anaplastic thyroid carcinoma.
J. Georgy, Harikrishna Kovilapu, Ashish Singh
· Current Opinion in Endocrino... · 0 citations